Pfizer wraps InnoPharma buyout; Strides Arcolab agrees to Shasun pickup;

@FiercePharma: FDA slaps cardiovascular warnings on Roche/Novartis asthma blockbuster Xolair. Story | Follow @FiercePharma

@TracyStaton: Bristol-Myers' oncology star lines up for lung cancer approval, leading the PD-1 pack. News | Follow @TracyStaton

@CarlyHFierce: Allergan buy Salix? Not so fast, say investors intent on Valeant vote. Article | Follow @CarlyHFierce

> Pfizer ($PFE) has completed its buyout of InnoPharma. Release

> India's Strides Arcolab has agreed to buy Shasun Pharma for $200 million in an all-stock deal. Report

> Baxter ($BAX) and Kamada have extended their supply agreement for emphysema drug Glassia. Release

> China is producing its first erectile dysfunction medicine treatment based on compound ingredients previously patented for Pfizer's ($PFE) Viagra. More

> CVS Caremark ($CVS) will pay $6 million to settle U.S. allegations that it knowingly failed to reimburse Medicaid for certain prescription drug costs. Report

Medical Device News

@FierceMedDev: Medtronic may revise $42.9B deal with Covidien under new tax rules. Story | Follow @FierceMedDev

@MichaelGFierce: Purdue team recreates tumor microenvironment to study #cancer nanomed delivery. More | Follow @MichaelGFierce

@VarunSaxena2: FierceMedicalDevices has learned that James V. Mazzo is on suspension as operating partner at life science VC Versant Ventures due to indictment. | Follow @VarunSaxena2

@EmilyWFierce: American Academy of Pediatrics backs IUDs as first-line choice for teens seeking long-term contraception. Article | Follow @EmilyWFierce

> Implanted pulley device could aid those with nerve damage to their hands. Story

> Court rules that FDA cannot rescind 510(k)s without notice and comment procedures. Article

Biotech News

@FierceBiotech: Just how big is the biosimilars business going to be in 5 years? Editor's Corner | Follow @FierceBiotech

@JohnCFierce: Tiny biotech, trumpeting reformulation of a muscle relaxer, shotgun R&D strategy - what's not to like? $TNXP plunges. Story | Follow @JohnCFierce

@DamianFierce: There are now 245 companies developing biosimilars around the globe, according to @Reuters. Article | Follow @DamianFierce

@EmilyMFierce: New Washington player joins push for NIH funding. Story | Follow @EmilyMFierce

> Tonix shares battered as lead fibromyalgia drug flops in PhIIb. Article

> Daiichi Sankyo bags leukemia drug in $410M Ambit buyout. News

> ESMO: Bristol-Myers, Roche, AstraZeneca, GSK, Merck jostle for spotlight. Story

> Alimera and pSivida finally win FDA approval for thrice-rejected drug. More

CRO News

> Evotec lends its R&D might to the multiple sclerosis cause. More

> Catalent partners up with Cingulate on two ADHD drugs. Article

> Post-IPO Ergomed keeps rolling with its risk-sharing partnerships. Report

> AstraZeneca moves away from outsourcing, at least in IT. Item

> GVK accused of tampering with data in Indian clinical trials. Article

Biotech IT News

> Medidata stung by $4.8M wire transfer fraud. News

> NIH backs database-driven approach to neuromuscular research. Report

> The FDA commits $16M to track prescription drug use. Item

> wins PCORI clinical trial matchmaking app competition. Story

> FDA's Mini-Sentinel set to graduate on October 1. More

Animal Health News

> Merial expands NexGard plant in Brazil with $25M infusion. News

> Elanco and Dow AgroSciences team up to meet global demand for food. Article

> Avacta unveils new test for diagnosing lymphoma in dogs. Story

> Study: No differences between genetically engineered and non-GE feed on animals. More

> UN's Food and Agriculture Organization warns of new strain of avian influenza virus. Item

And Finally... Rising wealth in Asia is spurring more "diseases of the affluent," a hospital operator says. More